SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-21-004453
Filing Date
2021-01-26
Accepted
2021-01-26 17:31:26
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea133811-f3_tizianalife.htm F-3 1212106
2 CONSENT OF MAZARS LLP ea133811ex23-1_tizianalife.htm EX-23.1 3867
3 GRAPHIC img_001.jpg GRAPHIC 11377
4 GRAPHIC img_002.jpg GRAPHIC 49119
5 GRAPHIC ex23-1_001.jpg GRAPHIC 12723
6 GRAPHIC ex23-1_002.jpg GRAPHIC 8551
7 GRAPHIC ex23-1_003.jpg GRAPHIC 197808
  Complete submission text file 0001213900-21-004453.txt   1602481
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-252441 | Film No.: 21555525
SIC: 2834 Pharmaceutical Preparations